The company revealed plans to delist from the Canadian Exchange, citing cost savings and improved liquidity on NASDAQ.

Historically, Curaleaf has been primarily focused on the medical cannabis market; however, in May 2019, Curaleaf acquired Cura Partners. The acquisition expanded Curaleaf’s stand-alone East ...

And that would be a fine development for Curaleaf and the rest of the ever-struggling marijuana industry. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position ...